Lv1
30 积分 2025-01-20 加入
Efficacy and safety of upadacitinib in patients with active ankylosing spondylitis (SELECT-AXIS 1): a multicentre, randomised, double-blind, placebo-controlled, phase 2/3 trial
7小时前
待确认
Ixekizumab for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 52-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
1天前
已完结
Additional risk of developing TB for household members with a TB case at home at intake: a 15-year study
4天前
已关闭
Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials
8天前
已完结
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis
12天前
已关闭
Incomplete response of inflammatory arthritis to TNFα blockade is associated with the Th17 pathway
1个月前
已完结
[Expert consensus on diagnosis and treatment of latent tuberculosis infection in patients with rheumatic diseases]
1个月前
已完结
Chinese Registry of Rheumatoid Arthritis (CREDIT) VI: Temporal Trends in Patients With Early Rheumatoid Arthritis and Moderate‐To‐Severe Disease Activity ‐ A Multicenter Cohort Study of Treatment Strategies and Outcomes
1个月前
已完结
Rheumatoid Arthritis — Common Origins, Divergent Mechanisms
1个月前
已完结
Rheumatoid arthritis
1个月前
已完结
皖公网安备34019202002308
